Effects of Regular Submaximal Exercise on Asthma Control and Quality of Life in Patients With Persistent Symptoms
NCT ID: NCT04395937
Last Updated: 2022-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2020-09-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the impact of submaximal physical exercise on quality of life, on symptomatic control, and on bronchial and systemic inflammatory markers in patients with persistant asthma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asthma Control: Increased Physical Activity in Young Adults
NCT04944199
Impact of Aerobic Exercise on Asthma Morbidity
NCT00953342
Exercise Training in Asthma
NCT00820716
Effect of Aerobic Training in Moderate or Severe Asthmatic Patients
NCT02033122
Effects of an Exercise Program for Children With Asthma
NCT02693301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators are planning a 12-week randomized controlled study to assess the effect of regular aerobic exercise on quality of life, asthma control, bronchial hyperresponsiveness and bronchial and systemic inflammation in patients with persistent asthma
The hypothesis is that regular physical exercise increases control and quality of life and reduces inflammation and bronchial hyperresponsiveness compared to simple physiotherapy sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
respiratory physiotherapy
exercises to improve the way of breathing
exercises
One hour twice a week to practice respiratory exercises, postural exercises, muscular exercises
respiratory physiotherapy and physical exercises
intensity determined by the VO2max measured during ergospirometric measure
exercises
One hour twice a week to practice respiratory exercises, postural exercises, muscular exercises
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercises
One hour twice a week to practice respiratory exercises, postural exercises, muscular exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18- 90 years
* ACQ \> 1.5
* stable background treatment comprising at least one inhaled corticosteroid or an anti-leukotriene
Exclusion Criteria
* severe osteoarthritis of the knees and hips
* unstable angor
* Severe uncontrolled hypertension
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Renaud Louis
Professor Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Liege
Liège, Liege, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
stephanie ziant
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B707202042981
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.